Question 1

What are the potential side effects of botulinum toxin injections?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function clinical trial (NCT00076687). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function clinical trial (NCT00076687). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the injection process involve, and how often will I need to come in for treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function clinical trial (NCT00076687). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests I need to undergo before starting this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function clinical trial (NCT00076687). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect in terms of improvement in my symptoms?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function clinical trial (NCT00076687). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this treatment affect my overall health, especially my lung function?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function clinical trial (NCT00076687). Contact the study team or your healthcare provider for specific answers.

What this study is about